Is Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-05 11:23:47As of 31 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. Daily moving averages also support a bullish stance. However, the KST shows a mildly bearish signal on the weekly timeframe, which slightly tempers the overall bullish outlook. In terms of performance, the stock has returned 66.13% year-to-date compared to the S&P 500's 16.30%, but it has underperformed over the past year with a return of -26.16% versus the S&P 500's 19.89%. Overall, the current technical stance is bullish with moderate strength....
Read MoreIs Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-04 11:35:34As of 31 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, supporting the bullish stance. The daily moving averages also indicate a bullish trend. However, the KST shows a mildly bearish signal on the weekly and bearish on the monthly, which introduces some caution. The Dow Theory remains mildly bullish on both weekly and monthly time frames. In terms of performance, the stock has returned 69.09% year-to-date, significantly outperforming the S&P 500's 16.30% return in the same period. However, over the past year, the stock has declined by 24.85%, while the S&P 500 has gained 19.89%. Overall, the current technical stance is bullish, but mixed signals from KST and the longer-term returns suggest a need for cautious optimism....
Read MoreIs Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-03 11:35:21As of 31 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. Daily moving averages also support a bullish stance. However, the KST shows a mildly bearish signal on the weekly and bearish on the monthly, which slightly tempers the overall bullish outlook. The Dow Theory reflects a mildly bullish stance on both weekly and monthly time frames. In terms of performance, the stock has returned 66.87% year-to-date, significantly outperforming the S&P 500's 16.30% return in the same period. However, over the past year, the stock has declined by 20.99%, while the S&P 500 has gained 19.89%. Overall, the current technical stance is bullish, driven primarily by strong momentum indicators despite some mixed signals from KST and Dow Theory....
Read MoreIs Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-11-02 11:19:25As of 31 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, supported by bullish signals from the Bollinger Bands and the daily moving averages. However, the KST indicates a mildly bearish stance on the weekly and a bearish stance on the monthly, which slightly tempers the overall bullish outlook. The Dow Theory shows a mildly bullish trend on both weekly and monthly time frames. In terms of performance, the stock has returned 66.87% year-to-date, significantly outperforming the S&P 500's 16.30% return in the same period, although it has underperformed over the 1-year and 5-year periods. Overall, the current technical stance is bullish, with moderate strength driven by several indicators....
Read More
Phathom Pharmaceuticals, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-28 15:56:10Phathom Pharmaceuticals, Inc. has recently revised its evaluation amid market dynamics, with its stock price showing a slight increase. The company has experienced significant volatility over the past year, with notable returns year-to-date, outperforming the S&P 500. Technical indicators present a mixed outlook on momentum.
Read MoreIs Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-28 11:44:50As of 24 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. Daily moving averages also support a bullish stance. However, the KST is mildly bearish on a weekly basis and bearish on a monthly basis, which slightly tempers the overall bullish outlook. In terms of performance, the stock has returned 66.63% year-to-date, significantly outperforming the S&P 500's 15.47% during the same period, although it has underperformed over the 1-year, 3-year, and 5-year horizons compared to the benchmark. Overall, the current technical stance is bullish with moderate strength....
Read MoreIs Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-27 11:55:52As of 24 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. Daily moving averages are also bullish, supporting the overall bullish stance. However, the KST shows a mildly bearish signal on the weekly and bearish on the monthly, which suggests some caution. The Dow Theory indicates a mildly bullish trend on both weekly and monthly time frames. Overall, the current technical stance is bullish with moderate strength. Multi-period return data is not available for comparison with the S&P 500....
Read MoreIs Phathom Pharmaceuticals, Inc. technically bullish or bearish?
2025-10-26 11:31:00As of 24 October 2025, the technical trend for Phathom Pharmaceuticals, Inc. has changed from mildly bullish to bullish. The current stance is bullish with a strong indication from the daily moving averages and weekly Bollinger Bands, both signaling bullish momentum. The MACD is bullish on a weekly basis, while the monthly MACD remains mildly bullish. However, the KST indicates a mildly bearish trend on the weekly and bearish on the monthly, suggesting some caution. In terms of performance, the stock has outperformed the S&P 500 over the past week and month, with returns of 4.40% and 15.54% respectively, compared to the S&P 500's 1.92% and 2.32%. However, the longer-term returns show a decline over the past year and five years, with the stock down 16.53% and 66.01%, while the S&P 500 has gained 16.90% and 95.99% in those periods. Overall, the current bullish trend is supported by several indicators, but c...
Read More
Phathom Pharmaceuticals Experiences Revision in Stock Evaluation Amid Market Dynamics
2025-10-20 15:29:25Phathom Pharmaceuticals, Inc. has recently revised its evaluation amid market fluctuations, with its stock price at $12.96. The company has experienced significant volatility over the past year, with a 52-week high of $19.50 and a low of $2.21. Recent trends suggest a potential recovery phase.
Read More





